Gastrointestinal

There are over three million people in the UK estimated to be suffering from Irritable Bowel Syndrome (IBS) and its variety of symptoms. More and more treatments for the currently incurable condition are being sought, with one of the increasingly popular treatment options being cannabidiol (CBD).

Ulcerative colitis is a persistent inflammatory bowel disease (IBD) characterised by inflammation in the inner lining of the colon and rectum. This chronic condition has a diverse range of symptoms. These include diarrhoea, rectal bleeding, abdominal pain and general discomfort. The severity of these symptoms can fluctuate significantly. 

CBD engages with the body's endocannabinoid system, a vital regulatory system involved in managing numerous physiological processes, such as inflammation and immune response. In the case of Inflammatory Bowel Disease (IBD), the immune system erroneously targets the gastrointestinal tract, resulting in persistent inflammation. CBD has shown the potential to influence this immune response and mitigate inflammation within the digestive system.

The cannabis sativa L. plant is one of the most versatile, and potentially therapeutically beneficial types of flora to ever grace this pale blue dot we call home. It is one of the fastest-growing plants, takes less water to cultivate than the vast majority of other crops, and has a wide range of applications due to not only the presence of cannabinoids, but also its true variability in terms of the production of textiles, paper products, and food items.

Inflammation is the body’s natural response to harmful stimuli like injuries and infection. It effectively quarantines the site of the injury and infection in order to attack any invading bodies or contaminants. In the modern world, however, there are more negative stimuli that can trigger inflammation than ever, from stressful living and working conditions to processed foods and airborne pollution. These can cause the immune system to attack healthy tissue.

Research has shown that medical cannabis has the potential to help with a variety of ailments and health issues, including the symptoms of Irritable Bowel Syndrome (IBS).

Many people suffering from Irritable Bowel Syndrome (IBS) are seeking out new complementary treatment options, such as cannabidiol (CBD), to treat symptomatic flare-ups. While there are conventional pharmaceutical options, some come with heavy side effects or simply do not bring the level of relief needed.

There is a significant body of research that suggests symptoms of irritable bowel syndrome (IBS) may be treated with medical cannabis, and more specifically, cannabidiol (CBD). Now, along with the increasing availability of CBD products through the NHS and private clinics (like Releaf) to treat certain conditions like IBS, it is worth understanding the benefits of CBD treatment, as well as its potential side effects and correct dosage amounts.

There are over three million people in the UK estimated to be suffering from irritable bowel syndrome (IBS) and its variety of symptoms. More and more treatments for the currently incurable condition are being sought, with one of the increasingly popular treatment options being medical cannabis, and one of the major cannabinoids produced by the plant - cannabidiol (CBD).

As more research is conducted into the potential therapeutic effects of medical cannabis and CBD oil, more possible benefits are discovered. One such discovery is the potential for CBD oil to help alleviate certain symptoms in people suffering from ulcerative colitis.

Crohn's disease is an inflammatory bowel disease (IBD) that affects the gastrointestinal tract, most often the small intestine and colon. Its milder symptoms include diarrhoea and fatigue. More severe cases may cause intense abdominal pain and impaired digestion, leading to potential malnutrition. Crohn's disease can also trigger very distressing complications such as ulcers and fissures.

Crohn's disease is an autoimmune condition that can have a significant impact on your quality of life. It is characterised by inflammation of the digestive tract, which can cause abdominal pain, diarrhoea, weight loss and fatigue. While there is no known cure for Crohn's disease, patients have a range of treatment options available to them here in the UK, with medical cannabis being one of them.

Crohn's disease is a chronic inflammatory bowel disease (IBD) that affects the gastrointestinal tract. It causes symptoms such as abdominal pain, diarrhoea, weight loss and fatigue. The condition can be difficult to manage, and traditional treatment methods may not always be effective. This has led some people to explore alternative, complementary therapies, such as medical cannabis.

Inflammatory Bowel Disease (IBD) is a group of conditions that cause inflammation in the digestive tract. Depending on their level of severity, they can be anything from frustrating inconveniences to life-altering health issues with potentially dangerous consequences.